文献速递呼吸危重症与机械通气

ARDS患者ECMO期间机械通气管理:国际多中心前瞻性队列研究

Mechanical Ventilation Management during Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome. An International Multicenter Prospective Cohort.
PubMed 文献 · Am J Respir Crit Care Med · 2019-01-01

该国际多中心前瞻性队列研究纳入23个ICU中350例因重症ARDS接受ECMO的患者,报告ECMO期间机械通气实践及与6个月结局的关联。ECMO启动后潮气量、平台压、驱动压、呼吸频率及机械功均明显降低,6个月生存率61%;ECMO前2天通气参数与生存无关,而年龄、液体平衡、乳酸及肾脏替代治疗需求与6个月死亡率独立相关。

要点

  • ECMO启动后普遍采用超保护性肺通气,潮气量、平台压及驱动压明显降低。
  • ECMO前2天通气参数与6个月生存无独立关联。
  • 年龄、液体正平衡、高乳酸及肾脏替代治疗需求与6个月死亡率独立相关。

核心结论

  • 在中等至高病例量的ECMO中心,ARDS患者ECMO期间普遍采用超保护性肺通气。
  • ECMO期间机械通气参数未影响患者预后,与既往观察不同。

研究设计与样本

  • 国际、多中心、前瞻性队列研究,纳入23个国际ICU在1年期间因ARDS接受ECMO的患者。
  • 共纳入350例患者,ECMO前PaO2/FiO2均值±SD为71±34 mm Hg。

主要发现

  • ECMO启动后潮气量由6.4±2.0降至3.7±2.0 ml/kg,平台压由32±7降至24±7 cm H2O。
  • 驱动压由20±7降至14±4 cm H2O,呼吸频率由26±8降至14±6次/分,机械功由26.1±12.7降至6.6±4.8 J/min。
  • ECMO前俯卧位通气使用率26%,神经肌肉阻滞剂使用率62%。
  • 6个月生存率为61%。
  • 多变量分析未发现ECMO前2天通气参数与生存的关联;时变Cox模型显示年龄较大、液体平衡较高、乳酸较高及ECMO期间肾脏替代治疗需求较多与6个月死亡率独立相关。

关键数值与推荐

  • ECMO期间较高潮气量和较低驱动压(可能为静态顺应性改善的标志)与更好结局相关。

临床怎么用

  • 在ECMO中心对重症ARDS患者可采用超保护性肺通气策略。
  • ECMO期间应关注液体平衡、乳酸水平及肾脏替代治疗需求等预后相关因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Current practices regarding mechanical ventilation in patients treated with extracorporeal membrane oxygenation (ECMO) for acute respiratory distress syndrome are unknown.Objectives: To report current practices regarding mechanical ventilation in patients treated with ECMO for severe acute respiratory distress syndrome (ARDS) and their association with 6-month outcomes.Methods: This was an international, multicenter, prospective cohort study of patients undergoing ECMO for ARDS during a 1-year period in 23 international ICUs.Measurements and Main Results: We collected demographics, daily pre- and per-ECMO mechanical ventilation settings and use of adjunctive therapies, ICU, and 6-month outcome data for 350 patients (mean ± SD pre-ECMO PaO2/FiO2 71 ± 34 mm Hg). Pre-ECMO use of prone positioning and neuromuscular blockers were 26% and 62%, respectively. Vt (6.4 ± 2.0 vs. 3.7 ± 2.0 ml/kg), plateau pressure (32 ± 7 vs. 24 ± 7 cm H2O), driving pressure (20 ± 7 vs. 14 ± 4 cm H2O), respiratory rate (26 ± 8 vs. 14 ± 6 breaths/min), and mechanical power (26.1 ± 12.7 vs. 6.6 ± 4.8 J/min) were markedly reduced after ECMO initiation. Six-month survival was 61%. No association was found between ventilator settings during the first 2 days of ECMO and survival in multivariable analysis. A time-varying Cox model retained older age, higher fluid balance, higher lactate, and more need for renal-replacement therapy along the ECMO course as being independently associated with 6-month mortality. A higher Vt and lower driving pressure (likely markers of static compliance improvement) across the ECMO course were also associated with better outcomes.Conclusions: Ultraprotective lung ventilation on ECMO was largely adopted across medium- to high-case volume ECMO centers. In contrast with previous observations, mechanical ventilation settings during ECMO did not impact patients' prognosis in this context.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Schmidt M, Pham T, Arcadipane A, et al. Mechanical Ventilation Management during Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome. An International Multicenter Prospective Cohort. Am J Respir Crit Care Med. 2019. PMID: 31144997. doi:10.1164/rccm.201806-1094OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。